Online Cognitive Control Training for Remitted Depressed Patients
1 other identifier
interventional
68
1 country
1
Brief Summary
This study evaluates the effectiveness of an internet-delivered cognitive control training as a preventive intervention for remitted depressed patients. Half of the participants will receive a cognitive control training, while the other half will receive a low cognitive load training that acts as an active control condition.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 18, 2017
CompletedStudy Start
First participant enrolled
September 1, 2017
CompletedFirst Posted
Study publicly available on registry
September 12, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 13, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 13, 2019
CompletedNovember 9, 2022
November 1, 2022
1.5 years
August 18, 2017
November 8, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in depressive symptomatology
Measured by the Beck Depression Inventory - II (BDI-II)
Assessed at pre-training assessment and at 6 months follow-up
Change in depressive symptomatology
Measured by the Depression Anxiety Stress Scales (DASS)
Assessed at pre-training assessment, at post-training assessment (within 1 week of completing the training), at 3 months follow-up and at 6 months follow-up
Change in depressive rumination (brooding)
Measured by the Ruminative Response Scale (RRS), especially the brooding subscale
Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
Secondary Outcomes (4)
Change in cognitive emotion regulation strategies
Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
Change in quality of life
Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
Remission from depression
Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
Resilience
Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
Other Outcomes (5)
User engagement
Assessed at post-training assessment (within 1 week of completing the training) and at 3 months follow-up
Threatening experiences
Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
Effortful control
Assessed at pre-training assessment and at 6 months follow-up
- +2 more other outcomes
Study Arms (2)
Cognitive Control Training
EXPERIMENTALA cognitive control training, consisting of 10 sessions of 15 minutes each, will be administered. The task in this training is an adaptive paced auditory serial addition task, where participants need to click on the sum of the last two heard digits.
Active Control Training
ACTIVE COMPARATORAn active control training, consisting of 10 sessions of 15 minutes each, will be administered. The task in this training is an adaptive low load cognitive task, where participants need to click on the last heard digit.
Interventions
10 sessions of an adaptive paced auditory serial addition task, each lasting 15 minutes, over the course of two weeks.
10 sessions of an low cognitive load task, each lasting 15 minutes, over the course of two weeks.
Eligibility Criteria
You may qualify if:
- History of ≥ 1 depressive episodes (major or bipolar)
- Currently in stable full or partial remission (≥ 3 months)
You may not qualify if:
- Major depressive disorder (current or less than 3 months in remission)
- Bipolar disorder (current or less than 3 months in remission)
- Psychotic disorder (current and/or previous)
- Neurological impairments (current and/or previous)
- Excessive substance abuse (current and/or previous)
- No ongoing psychotherapeutic treatment (maintenance treatment is allowed, but with a frequency of less than once every three weeks)
- Use of antidepressant medication is allowed if kept at a constant level
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Ghentlead
Study Sites (1)
Ghent University
Ghent, Oost-Vlaanderen, 9000, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ernst HW Koster, PhD
University Ghent
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 18, 2017
First Posted
September 12, 2017
Study Start
September 1, 2017
Primary Completion
March 13, 2019
Study Completion
March 13, 2019
Last Updated
November 9, 2022
Record last verified: 2022-11